Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Watkins

Showing results (621-630 of 937) with videos related to

Pageof 94
Sort By:
Journal of Clinical Pharmacology|January 26, 2023
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor AgonistElijah Weber, Islam R Younis, Cara Nelson, et al.
Archives of General Psychiatry|February 13, 2003
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first yearDominic H Lam, Edward R Watkins, Peter Hayward, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 23, 2003
Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challengeJ Campisi, M K Hansen, K A O'Connor, et al.
Trends in Neurosciences|November 16, 2016
Nitroxidative Signaling Mechanisms in Pathological PainPeter M Grace, Andrew D Gaudet, Vasiliki Staikopoulos, et al.
Brain, Behavior, and Immunity|March 17, 2015
(+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitationPeter M Grace, Kaori Shimizu, Keith A Strand, et al.
Journal of Neurochemistry|June 16, 2012
Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury modelPeter M Grace, Daniel Hurley, Daniel T Barratt, et al.
Clinical Pharmacokinetics|March 11, 2023
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) AgonistIslam Younis, Elijah Weber, Cara Nelson, et al.
Social Cognitive and Affective Neuroscience|April 19, 2022
Emerging ecophenotype: reward anticipation is linked to high-risk behaviours after sexual abusePia Pechtel, Jennifer Harris, Anke Karl, et al.
Journal of Medicinal Chemistry|January 22, 1998
Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitorsY Xia, S Chackalamannil, M Czarniecki, et al.
The Journal of Comparative Neurology|June 3, 2004
Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleusHeidi E W Day, Benjamin N Greenwood, Sayamwong E Hammack, et al.
Pageof 94

Showing results (621-630 of 937) with videos related to

Sort By:
Pageof 94
Journal of Clinical Pharmacology|January 26, 2023
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor AgonistElijah Weber, Islam R Younis, Cara Nelson, et al.
Archives of General Psychiatry|February 13, 2003
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first yearDominic H Lam, Edward R Watkins, Peter Hayward, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 23, 2003
Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challengeJ Campisi, M K Hansen, K A O'Connor, et al.
Trends in Neurosciences|November 16, 2016
Nitroxidative Signaling Mechanisms in Pathological PainPeter M Grace, Andrew D Gaudet, Vasiliki Staikopoulos, et al.
Brain, Behavior, and Immunity|March 17, 2015
(+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitationPeter M Grace, Kaori Shimizu, Keith A Strand, et al.
Journal of Neurochemistry|June 16, 2012
Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury modelPeter M Grace, Daniel Hurley, Daniel T Barratt, et al.
Clinical Pharmacokinetics|March 11, 2023
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) AgonistIslam Younis, Elijah Weber, Cara Nelson, et al.
Social Cognitive and Affective Neuroscience|April 19, 2022
Emerging ecophenotype: reward anticipation is linked to high-risk behaviours after sexual abusePia Pechtel, Jennifer Harris, Anke Karl, et al.
Journal of Medicinal Chemistry|January 22, 1998
Synthesis and evaluation of polycyclic pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitorsY Xia, S Chackalamannil, M Czarniecki, et al.
The Journal of Comparative Neurology|June 3, 2004
Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleusHeidi E W Day, Benjamin N Greenwood, Sayamwong E Hammack, et al.
Pageof 94